Chemours, DuPont and Corteva reach settlement agreement with Ohio for $110M

The Chemours (CC) announces that it, along with DuPont de Nemours (DD) and Corteva (CTVA), have reached settlement agreement with the State of Ohio for $110M to resolve claims associated with the manufacture and sale of per- and polyfluoroalkyl substances, or PFAS. The agreement resolves the State’s claims relating to releases of PFAS from the companies’ facilities including the Washington Works facility located along the Ohio-West Virginia border. The agreement also resolves claims relating to the manufacture and sale of PFAS-containing products and the State’s claims related to aqueous film-forming foam, or AFFF. Of the $110M total payment, 80% will be allocated by the State for conduct related to discharges from Washington Works, and the remaining 20% for other PFAS claims statewide, including AFFF. Consistent with the binding Memorandum of Understanding between Chemours, DuPont, and Corteva agreed in January 2021, Chemours will be responsible for 50% of the settlement costs, or $55M, with DuPont and Corteva responsible for the remaining 50%. Chemours believes this settlement furthers its objective to manage and resolve legacy liabilities, consistent with our MOU framework in coordination with DuPont and Corteva.